HEADER ISOMERASE 26-JAN-07 2OOW TITLE MIF BOUND TO A FLUORINATED OXIM DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE MIGRATION INHIBITORY FACTOR; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: MIF, PHENYLPYRUVATE TAUTOMERASE, GLYCOSYLATION-INHIBITING COMPND 5 FACTOR, GIF; COMPND 6 EC: 5.3.2.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MIF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11B KEYWDS ALTERNATIVE LIGAND-BINDING MODES, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.V.CRICHLOW,Y.AL-ABED,E.LOLIS REVDAT 9 25-DEC-24 2OOW 1 REMARK LINK REVDAT 8 30-AUG-23 2OOW 1 REMARK LINK REVDAT 7 18-OCT-17 2OOW 1 REMARK REVDAT 6 13-JUN-12 2OOW 1 MTRIX1 MTRIX2 MTRIX3 REVDAT 5 13-JUL-11 2OOW 1 VERSN REVDAT 4 12-MAY-09 2OOW 1 MTRIX1 MTRIX2 MTRIX3 REVDAT 3 24-FEB-09 2OOW 1 VERSN REVDAT 2 12-FEB-08 2OOW 1 JRNL REVDAT 1 05-JUN-07 2OOW 0 JRNL AUTH G.V.CRICHLOW,K.F.CHENG,D.DABIDEEN,M.OCHANI,B.ALJABARI, JRNL AUTH 2 V.A.PAVLOV,E.J.MILLER,E.LOLIS,Y.AL-ABED JRNL TITL ALTERNATIVE CHEMICAL MODIFICATIONS REVERSE THE BINDING JRNL TITL 2 ORIENTATION OF A PHARMACOPHORE SCAFFOLD IN THE ACTIVE SITE JRNL TITL 3 OF MACROPHAGE MIGRATION INHIBITORY FACTOR. JRNL REF J.BIOL.CHEM. V. 282 23089 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17526494 JRNL DOI 10.1074/JBC.M701825200 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 100.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 40990 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 848 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.79 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2350 REMARK 3 BIN R VALUE (WORKING SET) : 0.3020 REMARK 3 BIN FREE R VALUE : 0.3100 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 49 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2587 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 111 REMARK 3 SOLVENT ATOMS : 260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE STATISTICS LISTED BY RESOLUTION SHELL ARE FROM THE LAST ROUND REMARK 3 OF CNS REFINEMENT. MINOR MANUAL ADJUSTEMENTS WERE PERFORMED REMARK 3 AFTERWARDS. THE OVERALL STATISTICS REPRESENT THE FINAL MODEL. REMARK 3 INHIBITOR MOLECULES WERE MODELLED WITH PARTIAL OCCUPANCIES. REMARK 3 GLYCEROL MOLECULES MODELLED IN THE SAME ACTIVE SITES AS INHIBITOR REMARK 3 HAVE OCCUPANCIES WERE MODLLED AS HAVING OCCUPANCIES EQUAL TO 1- REMARK 3 (INHIBITOR OCCUPANCY FOR THAT ACTIVE SITE). THE RATIO OF REMARK 3 INHIBITOR : GLYCEROL OCCUPANCY FOR EACH ACTIVE SITE WAS DETERMINED REMARK 3 BY OCCUPANCY REFINEMENT IN CNS. REMARK 3 THE AROMATIC RING OF EACH INHIBITOR AND THE NEARBY SIDE CHAIN REMARK 3 OF LYS 32 SEEM TO SHOW SOME DISORDER (ESPECIALLY THE INHIBITOR REMARK 3 AROMATIC RING). THE COORDINATES INDICATE TOO SHORT A DISTANCE REMARK 3 BETWEEN LYS 32 IN CHAIN C AND THE AROMATIC RING OF THE NEARBY REMARK 3 INHIBITOR. HOWEVER, THEIR AVERAGE POSITIONS DO NOT NECESSARILY REMARK 3 REFLECT THEIR PROXIMITY AT ANY GIVEN TIME, DUE TO THIS DISORDER. REMARK 4 REMARK 4 2OOW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041404. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41057 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.44100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2OOH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50% SATURATED AMMONIUM SULFATE, 4% REMARK 280 ISOPROPANOL, 0.1 M TRIS(HYDROXYMETHYL)AMINOMETHAN; MIXED WITH REMARK 280 PROTEIN:INHIBITOR COMPLEX IN A 1:1 RATIO, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.80500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.62400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.89700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.62400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.80500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.89700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE HOMOTRIMER OF MIF, WHICH REMARK 300 IS PRESUMED TO BE THE PHYSIOLOGICALLY ACTIVE ENTITY REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 11 NE CZ NH1 NH2 REMARK 470 ARG A 88 NH1 NH2 REMARK 470 GLN B 35 CD OE1 NE2 REMARK 470 ARG C 11 NE CZ NH1 NH2 REMARK 470 LYS C 77 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS C 32 C5 OX4 C 200 1.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 108 139.81 -170.40 REMARK 500 SER A 111 -154.23 -150.93 REMARK 500 SER B 111 -156.07 -154.85 REMARK 500 TRP C 108 138.51 -171.74 REMARK 500 SER C 111 -154.07 -150.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 905 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OX4 A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OX4 C 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 706 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA C 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA C 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA C 803 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OOH RELATED DB: PDB REMARK 900 MIF BOUND TO OXIM-11 (AN IDENTICAL LIGAND WITH THE EXCEPTION THAT REMARK 900 OXIM-11 LACKS THE FLUORINE ATOM). DBREF 2OOW A 1 114 UNP P14174 MIF_HUMAN 1 114 DBREF 2OOW B 1 114 UNP P14174 MIF_HUMAN 1 114 DBREF 2OOW C 1 114 UNP P14174 MIF_HUMAN 1 114 SEQRES 1 A 114 PRO MET PHE ILE VAL ASN THR ASN VAL PRO ARG ALA SER SEQRES 2 A 114 VAL PRO ASP GLY PHE LEU SER GLU LEU THR GLN GLN LEU SEQRES 3 A 114 ALA GLN ALA THR GLY LYS PRO PRO GLN TYR ILE ALA VAL SEQRES 4 A 114 HIS VAL VAL PRO ASP GLN LEU MET ALA PHE GLY GLY SER SEQRES 5 A 114 SER GLU PRO CYS ALA LEU CYS SER LEU HIS SER ILE GLY SEQRES 6 A 114 LYS ILE GLY GLY ALA GLN ASN ARG SER TYR SER LYS LEU SEQRES 7 A 114 LEU CYS GLY LEU LEU ALA GLU ARG LEU ARG ILE SER PRO SEQRES 8 A 114 ASP ARG VAL TYR ILE ASN TYR TYR ASP MET ASN ALA ALA SEQRES 9 A 114 ASN VAL GLY TRP ASN ASN SER THR PHE ALA SEQRES 1 B 114 PRO MET PHE ILE VAL ASN THR ASN VAL PRO ARG ALA SER SEQRES 2 B 114 VAL PRO ASP GLY PHE LEU SER GLU LEU THR GLN GLN LEU SEQRES 3 B 114 ALA GLN ALA THR GLY LYS PRO PRO GLN TYR ILE ALA VAL SEQRES 4 B 114 HIS VAL VAL PRO ASP GLN LEU MET ALA PHE GLY GLY SER SEQRES 5 B 114 SER GLU PRO CYS ALA LEU CYS SER LEU HIS SER ILE GLY SEQRES 6 B 114 LYS ILE GLY GLY ALA GLN ASN ARG SER TYR SER LYS LEU SEQRES 7 B 114 LEU CYS GLY LEU LEU ALA GLU ARG LEU ARG ILE SER PRO SEQRES 8 B 114 ASP ARG VAL TYR ILE ASN TYR TYR ASP MET ASN ALA ALA SEQRES 9 B 114 ASN VAL GLY TRP ASN ASN SER THR PHE ALA SEQRES 1 C 114 PRO MET PHE ILE VAL ASN THR ASN VAL PRO ARG ALA SER SEQRES 2 C 114 VAL PRO ASP GLY PHE LEU SER GLU LEU THR GLN GLN LEU SEQRES 3 C 114 ALA GLN ALA THR GLY LYS PRO PRO GLN TYR ILE ALA VAL SEQRES 4 C 114 HIS VAL VAL PRO ASP GLN LEU MET ALA PHE GLY GLY SER SEQRES 5 C 114 SER GLU PRO CYS ALA LEU CYS SER LEU HIS SER ILE GLY SEQRES 6 C 114 LYS ILE GLY GLY ALA GLN ASN ARG SER TYR SER LYS LEU SEQRES 7 C 114 LEU CYS GLY LEU LEU ALA GLU ARG LEU ARG ILE SER PRO SEQRES 8 C 114 ASP ARG VAL TYR ILE ASN TYR TYR ASP MET ASN ALA ALA SEQRES 9 C 114 ASN VAL GLY TRP ASN ASN SER THR PHE ALA HET SO4 A 901 5 HET SO4 A 904 5 HET OX4 A 200 19 HET GOL A 701 6 HET GOL A 704 6 HET GOL A 706 6 HET SO4 B 902 5 HET GOL B 702 6 HET SO4 C 903 5 HET SO4 C 905 5 HET OX4 C 200 19 HET GOL C 703 6 HET GOL C 705 6 HET IPA C 801 4 HET IPA C 802 4 HET IPA C 803 4 HETNAM SO4 SULFATE ION HETNAM OX4 3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL) HETNAM 2 OX4 OXIME HETNAM GOL GLYCEROL HETNAM IPA ISOPROPYL ALCOHOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN IPA 2-PROPANOL FORMUL 4 SO4 5(O4 S 2-) FORMUL 6 OX4 2(C14 H16 F N O3) FORMUL 7 GOL 6(C3 H8 O3) FORMUL 17 IPA 3(C3 H8 O) FORMUL 20 HOH *260(H2 O) HELIX 1 1 PRO A 10 VAL A 14 5 5 HELIX 2 2 GLY A 17 GLY A 31 1 15 HELIX 3 3 PRO A 33 TYR A 36 5 4 HELIX 4 4 GLY A 68 ARG A 88 1 21 HELIX 5 5 SER A 90 ASP A 92 5 3 HELIX 6 6 ASN A 102 ALA A 104 5 3 HELIX 7 7 PRO B 10 VAL B 14 5 5 HELIX 8 8 GLY B 17 GLY B 31 1 15 HELIX 9 9 PRO B 33 TYR B 36 5 4 HELIX 10 10 GLY B 68 ARG B 88 1 21 HELIX 11 11 SER B 90 ASP B 92 5 3 HELIX 12 12 ASN B 102 ALA B 104 5 3 HELIX 13 13 PRO C 10 VAL C 14 5 5 HELIX 14 14 GLY C 17 GLY C 31 1 15 HELIX 15 15 PRO C 33 TYR C 36 5 4 HELIX 16 16 GLY C 68 ARG C 88 1 21 HELIX 17 17 SER C 90 ASP C 92 5 3 HELIX 18 18 ASN C 102 ALA C 104 5 3 SHEET 1 A 7 LEU B 46 PHE B 49 0 SHEET 2 A 7 ALA A 38 VAL A 42 -1 N VAL A 41 O LEU B 46 SHEET 3 A 7 MET A 2 THR A 7 1 N VAL A 5 O VAL A 42 SHEET 4 A 7 ALA A 57 SER A 63 -1 O HIS A 62 N MET A 2 SHEET 5 A 7 VAL A 94 ASP A 100 1 O TYR A 95 N CYS A 59 SHEET 6 A 7 VAL C 106 TRP C 108 -1 O GLY C 107 N ILE A 96 SHEET 7 A 7 SER C 111 THR C 112 -1 O SER C 111 N TRP C 108 SHEET 1 B 7 LEU A 46 PHE A 49 0 SHEET 2 B 7 ALA C 38 VAL C 42 -1 O VAL C 41 N LEU A 46 SHEET 3 B 7 MET C 2 THR C 7 1 N VAL C 5 O VAL C 42 SHEET 4 B 7 ALA C 57 SER C 63 -1 O LEU C 58 N ASN C 6 SHEET 5 B 7 VAL C 94 ASP C 100 1 O TYR C 95 N CYS C 59 SHEET 6 B 7 VAL B 106 TRP B 108 -1 N GLY B 107 O ILE C 96 SHEET 7 B 7 SER B 111 THR B 112 -1 O SER B 111 N TRP B 108 SHEET 1 C 7 SER A 111 THR A 112 0 SHEET 2 C 7 VAL A 106 TRP A 108 -1 N TRP A 108 O SER A 111 SHEET 3 C 7 VAL B 94 ASP B 100 -1 O ILE B 96 N GLY A 107 SHEET 4 C 7 ALA B 57 SER B 63 1 N CYS B 59 O TYR B 95 SHEET 5 C 7 MET B 2 THR B 7 -1 N MET B 2 O HIS B 62 SHEET 6 C 7 ALA B 38 VAL B 42 1 O VAL B 42 N VAL B 5 SHEET 7 C 7 LEU C 46 PHE C 49 -1 O LEU C 46 N VAL B 41 SITE 1 AC1 4 GLY A 68 GLY A 69 ALA A 70 GLN A 71 SITE 1 AC2 4 GLY A 65 LYS A 66 HOH A 389 ARG B 86 SITE 1 AC3 4 GLY B 68 GLY B 69 ALA B 70 GLN B 71 SITE 1 AC4 5 GLY C 68 GLY C 69 ALA C 70 GLN C 71 SITE 2 AC4 5 HOH C 404 SITE 1 AC5 4 ARG A 86 GLY C 65 LYS C 66 HOH C 450 SITE 1 AC6 14 PRO A 1 MET A 2 LYS A 32 TYR A 36 SITE 2 AC6 14 HIS A 62 SER A 63 ILE A 64 VAL A 106 SITE 3 AC6 14 GLY B 17 GLU B 21 GLN B 24 TYR B 95 SITE 4 AC6 14 ASN B 97 HOH B 380 SITE 1 AC7 13 GLU A 21 GLN A 24 TYR A 95 ASN A 97 SITE 2 AC7 13 HOH A 350 PRO C 1 MET C 2 LYS C 32 SITE 3 AC7 13 HIS C 62 SER C 63 ILE C 64 MET C 101 SITE 4 AC7 13 VAL C 106 SITE 1 AC8 6 PRO A 1 MET A 2 HIS A 62 VAL A 106 SITE 2 AC8 6 TYR B 95 ASN B 97 SITE 1 AC9 8 ALA A 114 ARG B 11 VAL B 14 PRO B 15 SITE 2 AC9 8 GLY B 17 PHE B 18 LEU B 19 LEU C 46 SITE 1 BC1 9 GLN A 35 ASP A 92 HOH A 250 GLY B 50 SITE 2 BC1 9 SER B 52 ARG B 93 HOH B 210 HOH B 239 SITE 3 BC1 9 IPA C 801 SITE 1 BC2 7 PRO B 1 MET B 2 HIS B 62 SER B 63 SITE 2 BC2 7 ILE B 64 HOH B 426 ASN C 97 SITE 1 BC3 6 TYR A 95 ASN A 97 PRO C 1 MET C 2 SITE 2 BC3 6 HIS C 62 SER C 63 SITE 1 BC4 7 VAL A 14 PRO A 15 PHE A 18 LEU A 19 SITE 2 BC4 7 ALA C 114 HOH C 249 HOH C 344 SITE 1 BC5 6 GLN A 35 HOH A 246 GOL A 706 GLY B 50 SITE 2 BC5 6 GLN C 35 TRP C 108 SITE 1 BC6 3 GLY C 17 LEU C 19 SER C 20 SITE 1 BC7 4 GLY C 17 PHE C 18 LEU C 19 SER C 20 CRYST1 67.610 67.794 87.248 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014791 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014751 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011462 0.00000 MTRIX1 1 1.000000 0.000000 0.000000 0.00000 1 MTRIX2 1 0.000000 1.000000 0.000000 0.00000 1 MTRIX3 1 0.000000 0.000000 1.000000 0.00000 1 MTRIX1 2 -0.999900 -0.011200 0.003100 174.44280 1 MTRIX2 2 0.010800 -0.793200 0.608900 -1.51400 1 MTRIX3 2 -0.004400 0.608900 0.793200 0.70450 1